...
首页> 外文期刊>Journal of atherosclerosis and thrombosis. >A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy
【24h】

A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy

机译:脂蛋白肾小球病患者的新型突变ApoE2仓敷(R158P)

获取原文
           

摘要

Lipoprotein glomerulopathy (LPG) is a rare glomerulopathy caused by lipoprotein thrombi. In almost all cases of LPG, several apolipoprotein (apo) E mutations were reported. Here, we present a case of LPG caused by a novel mutation that we named ApoE2 Kurashiki, which substitutes arginine with proline at apoE codon 158. ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R158C allele. ApoE2 Kurashiki substitutes at the same codon and cannot be distinguished from common apoE2 by stan-dard apoE genotyping or phenotyping.
机译:脂蛋白肾小球病(LPG)是由脂蛋白血栓引起的罕见肾小球病。在几乎所有的LPG病例中,都报告了几种载脂蛋白(apo)E突变。在这里,我们介绍了一个由新突变导致的LPG案例,我们将其命名为ApoE2 Kurashiki,该突变在apoE密码子158处用脯氨酸替代精氨酸。ApoE2多态性因其与III型高脂蛋白血症的关系而闻名,常见的apoE2亚型由R158C等位基因。 ApoE2仓敷(Kurashiki)替换为同一密码子,无法通过标准apoE基因分型或表型区别于普通apoE2。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号